Choosing a research supplier is easier to defend when the decision is documented before the first experiment. A decision record should show what the laboratory needed, which evidence was reviewed and why the material was accepted. It should not be a list of impressions about a website.

Start with requirements rather than scores

Write down the exact chemical identity and the quality attributes relevant to the study. Define which documents and results are required, which are optional and which unresolved issues would prevent acceptance. This avoids awarding points for attractive features while overlooking a critical gap.

FDA's Q7 guidance offers a pharmaceutical-quality reference for supplier qualification, documentation and traceability. It is useful as a framework, but it should not be presented as an audit certificate for a research supplier or as proof that every Q7 provision applies to every reagent purchase. FDA Q7 guidance for active pharmaceutical ingredient quality

Keep evidence and judgment separate

The record can distinguish observed facts, supplier statements and the laboratory's conclusions. For example, a report may state a purity result, while the reviewer concludes that additional identity information is needed. The reason for that conclusion should be visible.

Analytical methods also require context. FDA's Q2 guidance describes the importance of demonstrating suitability for the procedure's purpose. A report should therefore be evaluated against the intended assay, not merely against a percentage printed in bold. FDA Q2 R2 analytical procedure validation guidance

Include how changes will be handled. A new manufacturer, specification or analytical method may require reassessment. A supplier accepted for one project should not automatically be accepted for every future use.

AXON can provide this decision framework without claiming that it has audited named companies. The final record belongs to the responsible institution's quality process. Human treatment requires a separate regulated pathway; acceptance of a reagent for an experiment does not establish patient suitability.